providing effective relief from heartburn

and anti-inflammatory benefits

Moxifloxacin: 5 mg

Targeted MASH Therapy: The first FDA-approved oral medication specifically indicated to treat MASH (NASH) with moderate to advanced liver fibrosis

Moxtu (Meloxicam) 7.5mg, 30 Ct - SJG Pharma Pack Size:30 Tablets providing effective relief from heartburnMoxtu contains Meloxicam 7. 5 mg, a non steroidal anti inflammatory drug (NSAID) used to relieve pain and inflammation associated with conditions such as osteoarthritis, rheumatoid arthritis, and other musculoskeletal disorders. Meloxicam works by inhibiting cyclooxygenase (COX) enzymes, reducing the production of prostaglandins responsible for pain, swelling, and inflammation. This lower strength formulation (7. 5 mg) is often suitable for patients